World Congress on
Endometriosis 2025
At the recent World Congress on Endometriosis, leading experts from around the globe gathered to discuss practical approaches to pain management from adolescence through to fertility care at the Gedeon Richter-sponsored symposium Delving into Endometriosis Pain Management: From Adolescence to Family Planning. They examined diagnostic challenges, medical and surgical treatment approaches, fertility preservation, and strategies to optimise care.
Therapies such as Ryeqo®, a GnRH antagonist with add-back therapy1, were discussed for their role in symptom management.
Delving into Endometriosis Pain Management: From Adolescence to Family Planning. (Full Video 58min)
Symposium in Bitesize
QnA
Prof Rebecca Dean's Talk
Prof Jason Abbott's Talk
Prof Juan A Garcia-Velasco's Talk

Abbreviations: BMD, bone mineral density; GnRH, gonadotropin-releasing hormone; PBS, PharmaceuticalBenefits Scheme.References: 1. Ryeqo® Approved Product Information. January 2024. Ryeqo® is a registered trademark of Gedeon Richter. © Gedeon Richter Australia Pty Ltd ABN 98 602 550 274.Suite 902/15 Blue St, North Sydney NSW 2060. COMS-0359-Aug-2025. Date of preparation: AUG 2025.